PLUS1
Period:
Draw Mode:
| Volume | 257 |
|
|||||
| News | - | ||||||
| Day High | 3.08 | Low High |
|||||
| Day Low | 3.05 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Eliem Therapeutics Inc | ELYM | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 3.08 | 03:48:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.05 | 3.05 | 3.08 | 3.08 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8 | 257 | US$ 3.08 | US$ 792 | - | 2.21 - 8.62 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 03:14:01 | 40 | US$ 3.09 | USD |
Eliem Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 81.83M | 26.57M | 8.08M | US$ - | US$ - | -1.72 | -0.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 1.20% |
Eliem Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 17/3/2023 | 07:31 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 15/3/2023 | 08:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 09/3/2023 | 08:01 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 07/3/2023 | 08:53 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 07/3/2023 | 08:50 | Edgar (US Regulatory) | Annual Report (10-k) |
| 07/3/2023 | 08:10 | GlobeNewswire Inc. | Eliem Therapeutics Reports Fourth Quarter and Year-End.. |
| 15/2/2023 | 06:23 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 10/2/2023 | 08:01 | GlobeNewswire Inc. | Eliem Therapeutics Provides Strategic Update and Announces.. |
| 09/2/2023 | 08:36 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 21/12/2022 | 08:03 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 30/11/2022 | 23:00 | GlobeNewswire Inc. | Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx.. |
| 16/11/2022 | 18:55 | TipRanks | SVB Securities Sticks to Their Buy Rating for Eliem.. |
Historical ELYM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.21 | 3.50 | 3.0078 | 3.13 | 8,917 | -0.13 | -4.05% |
| 1 Month | 3.59 | 3.65 | 2.59 | 3.15 | 9,832 | -0.51 | -14.21% |
| 3 Months | 4.05 | 4.75 | 2.21 | 3.35 | 18,256 | -0.97 | -23.95% |
| 6 Months | 3.28 | 4.75 | 2.21 | 3.33 | 13,480 | -0.20 | -6.1% |
| 1 Year | 8.48 | 8.62 | 2.21 | 3.65 | 69,032 | -5.40 | -63.68% |
| 3 Years | 16.25 | 29.69 | 2.21 | 10.23 | 83,439 | -13.17 | -81.05% |
| 5 Years | 16.25 | 29.69 | 2.21 | 10.23 | 83,439 | -13.17 | -81.05% |